Clinical Trials
6 trialsNCT02184416 2026-02-27
ADONIS
Pfizer
Completed
NCT01210482 2024-09-25
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer
Completed
NCT00700258 2024-09-23
STAR-TOR
Pfizer
Completed
NCT01367457 2016-04-27
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
Pfizer
Completed
NCT01781442 2013-05-01
A Post Marketing Surveillance As Required By Philippine Food And Drug Administration
Pfizer
Withdrawn
NCT00195299 2007-12-27
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck
Wyeth is now a wholly owned subsidiary of Pfizer
Completed